Andrés Quesada

Andrés Quesada

Auto-generated profile, based on publicly available information

Andrés Quesada

Servicio de Nefrología, Hospital Universitario Virgen de las Nieves, FIBAO, Granada. España

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2002 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
AQA Quesada
A Quesada
Juan SainzJuan Sainz
Juan Sainz
RWR Wangensteen
R Wangensteen
Isabel Rodríguez-GómezIsabel Rodríguez-Gómez
Isabel Rodríguez-Gómez
FVF Vargas
F Vargas
AOA Osuna
A Osuna
OBJECTIVE: Thyroid disorders are accompanied by important changes in haemodynamic and cardiac functions and renal sodium handling. Since nitric oxide (NO) plays a crucial role in regulating vascular tone and renal sodium excretion, the present paper was designed to determine whether changes in the activity of NO synthase (NOS) participate in the cardiovascular and renal manifestations of thyroid disorders. METHODS: We measured NOS activity in the heart (left and right ventricles), vessels (aorta and cava) and kidney (cortex and medulla) of euthyroid, hyperthyroid and hypothyroid rats after 6 weeks of treatment. NOS activity was determined by measuring the conversion of L-[(3)H]-arginine to L-[(3)H]-citruline. RESULTS: NOS activity was higher in all tissues from hyperthyroid rats when compared with controls, except in the right ventricle. In the hypothyroid group, NOS activity showed a more heterogeneous pattern, with significant increases in both ventricles but significant reduction in the aorta, while in the vena cava, renal cortex and medulla the enzyme activity also tended to be higher, but significance was not reached. CONCLUSIONS: These data indicated that NOS activity was upregulated in tissues primarily related to blood pressure control in hyperthyroid rats, suggesting that an increased NO production may contribute to the hyperdynamic circulation in hyperthyroidism and may have a protective homeostatic effect in the target organs of the hypertension that accompanies this endocrine disease. The aortic and renal findings in hypothyroid rats suggested a possible role for NOS in the increased peripheral resistance and the normal pressure-diuresis-natriuresis response of these hypotensive animals, although hypothyroidism produced a heterogeneous tissue response in NOS activity.

5 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AQAndrés Quesada
Andrés Quesada
FVFélix Vargas
Félix Vargas
SMSebastián Montoro-Molina
Sebastián Montoro-Molina
FOFrancisco O'VAlle
Francisco O'VAlle
MRMaría Dolores Rodríguez-Martínez
María Dolores Rodríguez-Martínez
Rosemary WangensteenRosemary Wangensteen
Rosemary Wangensteen
This study analyzes the fluorimetric determination of alanyl- (Ala), glutamyl- (Glu), leucyl-cystinyl- (Cys) and aspartyl-aminopeptidase (AspAp) urinary enzymatic activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats. Male Wistar rats (n = 8 each group) received a single subcutaneous injection of either saline or cisplatin 3.5 or 7 mg/kg, and urine samples were taken at 0, 1, 2, 3 and 14 days after treatment. In urine samples we determined Ala, Glu, Cys and AspAp activities, proteinuria, N-acetyl-β-D-glucosaminidase (NAG), albumin, and neutrophil gelatinase-associated lipocalin (NGAL). Plasma creatinine, creatinine clearance and renal morphological variables were measured at the end of the experiment. CysAp, NAG and albumin were increased 48 hours after treatment in the cisplatin 3.5 mg/kg treated group. At 24 hours, all urinary aminopeptidase activities and albuminuria were significantly increased in the cisplatin 7 mg/kg treated group. Aminopeptidase urinary activities correlated (p0.259) with plasma creatinine, creatinine clearance and/or kidney weight/body weight ratio at the end of the experiment and they could be considered as predictive biomarkers of renal injury severity. ROC-AUC analysis was made to study their sensitivity and specificity to distinguish between treated and untreated rats at day 1. All aminopeptidase activities showed an AUC>0.633. We conclude that Ala, Cys, Glu and AspAp enzymatic activities are early and predictive urinary biomarkers of the renal dysfunction induced by cisplatin. These determinations can be very useful in the prognostic and diagnostic of renal dysfunction in preclinical research and clinical practice.

1 December 2012 in Hypertension
Verified
Journal Article
Closed access
PDF file
Isabel Rodríguez-GómezIsabel Rodríguez-Gómez
Isabel Rodríguez-Gómez
Rosemary WangensteenRosemary Wangensteen
Rosemary Wangensteen
RPRocío Pérez-Abud
Rocío Pérez-Abud
AQAndrés Quesada
Andrés Quesada
RMRaimundo G. del Moral
Raimundo G. del Moral
Félix VargasFélix Vargas
Félix Vargas
We investigated the effects of uninephrectomy (UNX) in 6-week-old male and female rats on blood pressure (BP), renal sodium handling, salt sensitivity, oxidative stress, and renal injury over 18 months postsurgery, studying control sham-operated and UNX-operated rats at 6, 12, and 18 months postsurgery, evaluating their renal sodium handling, BP, urinary isoprostanes, N -acetyl-β- d -glucosaminidase, and proteinuria before and after a 2-week high-salt intake period. At 18 months, plasma variables were measured and kidney samples were taken for the analysis of renal morphology and tissue variables. BP was increased at 6 months in male UNX rats versus controls and at 12 and 18 months in both male and female UNX rats and was increased in male versus female UNX groups at 18 months. UNX did not affect water and sodium excretion under basal conditions and after the different test in male and female rats at different ages. However, the renal function curve was shifted to the right in both male and female UNX rats. High-salt intake increased BP in both UNX groups at 6, 12, and 18 months and in the female control group at 18 months, and it increased proteinuria, N -acetyl-β- d -glucosaminidase, and isoprostanes in both UNX groups throughout the study. Renal lesions at 18 months were more severe in male versus female UNX rats. In summary, long-term UNX increased the BP, creatinine, proteinuria, pathological signs of renal injury, and salt sensitivity. Earlier BP elevation was observed and morphological lesions were more severe in male than in female UNX rats.

4 December 2014 in Proteomics – Clinical Applications
Verified
Journal Article
Closed access
PDF file
SMSebastián Montoro‐Molina
Sebastián Montoro‐Molina
AQAndrés Quesada
Andrés Quesada
PZPiedad V. Zafra‐Ruiz
Piedad V. Zafra‐Ruiz
FOFrancisco O'VAlle
Francisco O'VAlle
FVFélix Vargas
Félix Vargas
Rosemary WangensteenRosemary Wangensteen
Rosemary Wangensteen

20 February 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
JCJavier Carmona-Cortés
Javier Carmona-Cortés
Isabel Rodríguez-GómezIsabel Rodríguez-Gómez
Isabel Rodríguez-Gómez
Rosemary WangensteenRosemary Wangensteen
Rosemary Wangensteen
IFInmaculada Banegas Font
Inmaculada Banegas Font
AGAngel Garcia-Lora
Angel Garcia-Lora
Félix VargasFélix Vargas
Félix Vargas

11 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AQAndrés Quesada
Andrés Quesada
SBSegarra Ana Belen
Segarra Ana Belen
SMSebastián Montoro-Molina
Sebastián Montoro-Molina
MGMaría del Carmen de Gracia
María del Carmen de Gracia
AOAntonio Osuna
Antonio Osuna
Rosemary WangensteenRosemary Wangensteen
Rosemary Wangensteen
The aim of this work was to investigate if the content of glutamyl aminopeptidase (GluAp) in microvesicular and exosomal fractions of urine is related with renal dysfunction in cisplatin-treated rats. Urine samples were collected 24 hours after injection of cisplatin (7 mg/kg, n = 10) or saline serum (n = 10), and they were subjected to differential centrifugation at 1.000, 17.000 and 200.000 g to obtain microvesicular and exosomal fractions. GluAp was measured with a commercial ELISA kit in both fractions. Serum creatinine (SCr) and body weight were measured 15 days after treatment. We analyzed if early excretion of GluAp in microsomal and exosomal fractions was correlated with final SCr and body weight increase. In a second experiment, enzymatic activities of GluAp and alanyl aminopeptidase (AlaAp) in urine, microvesicular and exosomal fractions were measured three days after injection. We analyzed the correlation of both markers with SCr determined at this point. Finally, we studied the expression of GluAp and extracellular vesicles markers Alix and tumor susceptibility gene (TSG101) in both fractions by immunoblotting. GluAp excretion was increased in all fractions of urine after cisplatin treatment, even if data were normalized per mg of creatinine, per body weight or per total protein content of each fraction. We found significant predictive correlations with SCr concentration, and inverse correlations with body weight increase determined 15 days later. Three days after injection, aminopeptidasic activities were markedly increased in all fractions of urine in cisplatin-treated rats. The highest correlation coefficient with SCr was found for GluAp in microvesicular fraction. Increase of GluAp in microvesicular and exosomal fractions from cisplatin-treated rats was confirmed by immunoblotting. Alix and TSG101 showed different patterns of expression in each fraction. Determination of GluAp content or its enzymatic activity in microvesicular and exosomal fractions of urine is an early and predictive biomarker of renal dysfunction in cisplatin-induced nephrotoxicity. Measurement of GluAp in these fractions can serve to detect proximal tubular damage independently of glomerular filtration status.